PDZK1IP1
From Wikipedia, the free encyclopedia
PDZK1 interacting protein 1
|
||||||||
Identifiers | ||||||||
Symbol(s) | PDZK1IP1; DD96; MAP17; RP1-18D14.5; SPAP | |||||||
External IDs | OMIM: 607178 MGI: 1914432 HomoloGene: 4213 | |||||||
|
||||||||
RNA expression pattern | ||||||||
Orthologs | ||||||||
Human | Mouse | |||||||
Entrez | 10158 | 67182 | ||||||
Ensembl | ENSG00000162366 | ENSMUSG00000028716 | ||||||
Uniprot | Q13113 | Q9CQH0 | ||||||
Refseq | NM_005764 (mRNA) NP_005755 (protein) |
NM_026018 (mRNA) NP_080294 (protein) |
||||||
Location | Chr 1: 47.42 - 47.43 Mb | Chr 4: 114.59 - 114.59 Mb | ||||||
Pubmed search | [1] | [2] |
PDZK1 interacting protein 1, also known as PDZK1IP1, is a human gene.[1]
[edit] References
[edit] Further reading
- Kocher O, Cheresh P, Lee SW (1996). "Identification and partial characterization of a novel membrane-associated protein (MAP17) up-regulated in human carcinomas and modulating cell replication and tumor growth.". Am. J. Pathol. 149 (2): 493-500. PMID 8701988.
- Kocher O, Comella N, Tognazzi K, Brown LF (1998). "Identification and partial characterization of PDZK1: a novel protein containing PDZ interaction domains.". Lab. Invest. 78 (1): 117-25. PMID 9461128.
- Kocher O, Cheresh P, Brown LF, Lee SW (1999). "Identification of a novel gene, selectively up-regulated in human carcinomas, using the differential display technique.". Clin. Cancer Res. 1 (10): 1209-15. PMID 9815914.
- Göttgens B, Barton LM, Chapman MA, et al. (2002). "Transcriptional regulation of the stem cell leukemia gene (SCL)--comparative analysis of five vertebrate SCL loci.". Genome Res. 12 (5): 749-59. doi: . PMID 11997341.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899-903. doi: . PMID 12477932.
- Silver DL, Wang N, Vogel S (2003). "Identification of small PDZK1-associated protein, DD96/MAP17, as a regulator of PDZK1 and plasma high density lipoprotein levels.". J. Biol. Chem. 278 (31): 28528-32. doi: . PMID 12754212.
- Pribanic S, Gisler SM, Bacic D, et al. (2003). "Interactions of MAP17 with the NaPi-IIa/PDZK1 protein complex in renal proximal tubular cells.". Am. J. Physiol. Renal Physiol. 285 (4): F784-91. doi: . PMID 12837682.
- Gisler SM, Pribanic S, Bacic D, et al. (2004). "PDZK1: I. a major scaffolder in brush borders of proximal tubular cells.". Kidney Int. 64 (5): 1733-45. doi: . PMID 14531806.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121-7. doi: . PMID 15489334.
- Gregory SG, Barlow KF, McLay KE, et al. (2006). "The DNA sequence and biological annotation of human chromosome 1.". Nature 441 (7091): 315-21. doi: . PMID 16710414.
- Guijarro MV, Castro ME, Romero L, et al. (2007). "Large scale genetic screen identifies MAP17 as protein bypassing TNF-induced growth arrest.". J. Cell. Biochem. 101 (1): 112-21. doi: . PMID 17230460.
- Guijarro MV, Leal JF, Fominaya J, et al. (2007). "MAP17 overexpression is a common characteristic of carcinomas.". Carcinogenesis 28 (8): 1646-52. doi: . PMID 17426052.
- Guijarro MV, Leal JF, Blanco-Aparicio C, et al. (2007). "MAP17 enhances the malignant behavior of tumor cells through ROS increase.". Carcinogenesis 28 (10): 2096-104. doi: . PMID 17548903.